Skip to main content
. 2022 Oct 27;13:1059133. doi: 10.3389/fimmu.2022.1059133

Figure 3.

Figure 3

Therapeutic approaches hypothesized or in clinical use, for the treatment of EBV-associated malignancies. Shown are broad categories of treatments (red), subcategories (bold) and specific examples (italicized). HDAC: Histone deacetylase; DNMT: DNA methyltransferase; R-CHOP: Rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.